As a consequence of the results discussed above, it can be concluded that the absence of WNT3a-induced signaling (or effective antagonism, for example by non-canonical Wnts [21]) towards BAFs appears to be of crucial importance for aromatase expression in ER-positive breast cancers. Here, CYP19A1 is linked to breast carcinoma.